146 related articles for article (PubMed ID: 2755145)
1. Anesthetized rabbit as a model for ischemia- and reperfusion-induced arrhythmias: effects of quinidine and bretylium.
Coker SJ
J Pharmacol Methods; 1989 Jul; 21(4):263-79. PubMed ID: 2755145
[TBL] [Abstract][Full Text] [Related]
2. Ischemia-induced conduction delay and ventricular arrhythmias: comparative electropharmacology of bethanidine sulfate and bretylium tosylate.
Kabell G
J Cardiovasc Pharmacol; 1989 Mar; 13(3):471-82. PubMed ID: 2471895
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiologic effects of bretylium tosylate on the canine heart during coronary artery occlusion and reperfusion.
Gibson JK; Stewart JR; Li YP; Lucchesi BR
J Cardiovasc Pharmacol; 1983; 5(4):517-24. PubMed ID: 6193345
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial K ATP channel activation is important in the antiarrhythmic and cardioprotective effects of non-hypotensive doses of nicorandil and cromakalim during ischemia/reperfusion: a study in an intact anesthetized rabbit model.
Das B; Sarkar C
Pharmacol Res; 2003 Jun; 47(6):447-61. PubMed ID: 12741997
[TBL] [Abstract][Full Text] [Related]
5. Effects of SQ 26,533 on reperfusion arrhythmias, ST-segment elevation and on infarct size in anesthetized dogs.
Saini RK; Fulmor IE; Parham CS; Antonaccio MJ
J Pharmacol Exp Ther; 1986 Apr; 237(1):1-8. PubMed ID: 3958960
[TBL] [Abstract][Full Text] [Related]
6. Effects of administration of nicorandil or bimakalim prior to and during ischemia or reperfusion on survival rate, ischemia/reperfusion-induced arrhythmias and infarct size in anesthetized rabbits.
Das B; Sarkar C; Karanth KS
Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):383-96. PubMed ID: 11692221
[TBL] [Abstract][Full Text] [Related]
7. Calcium antagonists and acute myocardial ischemia: comparative effects of gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, epicardial conduction times, and ventricular fibrillation thresholds.
Gülker H; Haverkamp W; Hindricks G; Bender F
Cardiovasc Drugs Ther; 1987 Dec; 1(4):367-76. PubMed ID: 3154673
[TBL] [Abstract][Full Text] [Related]
8. Prevention of ventricular fibrillation by bretylium in a conscious canine model of sudden coronary death.
Holland K; Patterson E; Lucchesi BR
Am Heart J; 1983 May; 105(5):711-7. PubMed ID: 6846113
[TBL] [Abstract][Full Text] [Related]
9. Prevention of chronic canine ventricular tachyarrhythmias with bretylium tosylate.
Patterson E; Gibson JK
Circulation; 1981 Nov; 64(5):1045-50. PubMed ID: 7285294
[TBL] [Abstract][Full Text] [Related]
10. Noradrenaline, infused locally, reduces arrhythmia severity during coronary artery occlusion in anaesthetised dogs.
Végh A; Parratt JR
Cardiovasc Res; 2002 Jul; 55(1):53-63. PubMed ID: 12062708
[TBL] [Abstract][Full Text] [Related]
11. Attenuation by R 56865, a novel cytoprotective drug, of regional myocardial ischemia- and reperfusion-induced electrocardiographic disturbances in anesthetized rabbits.
Verscheure Y; Pouget G; De Courtois F; Le Grand B; John GW
J Cardiovasc Pharmacol; 1995 Jan; 25(1):126-33. PubMed ID: 7723341
[TBL] [Abstract][Full Text] [Related]
12. Is the sarcolemmal or mitochondrial K(ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model?
Das B; Sarkar C
Life Sci; 2005 Jul; 77(11):1226-48. PubMed ID: 15964023
[TBL] [Abstract][Full Text] [Related]
13. Cardiomyocyte mitochondrial KATP channels participate in the antiarrhythmic and antiinfarct effects of KATP activators during ischemia and reperfusion in an intact anesthetized rabbit model.
Das B; Sarkar C
Pol J Pharmacol; 2003; 55(5):771-86. PubMed ID: 14704474
[TBL] [Abstract][Full Text] [Related]
14. Protection by carbocromene and molsidomine against arrhythmias occurring during coronary artery occlusion and reperfusion in dogs.
Fiedler VB; Kettenbach B; Göbel H; Nitz RE
J Cardiovasc Pharmacol; 1985; 7(5):964-70. PubMed ID: 2413309
[TBL] [Abstract][Full Text] [Related]
15. Bretylium tosylate: a newly available antiarrhythmic drug for ventricular arrhythmias.
Heissenbuttel RH; Bigger JT
Ann Intern Med; 1979 Aug; 91(2):229-38. PubMed ID: 380436
[TBL] [Abstract][Full Text] [Related]
16. The antiarrhythmic and antifibrillatory actions of bretylium and its o-iodobenzyl trimethylammonium analog, UM-360.
Kniffen FJ; Lomas TE; Counsell RE; Lucchesi BR
J Pharmacol Exp Ther; 1975 Jan; 192(1):120-8. PubMed ID: 1123718
[TBL] [Abstract][Full Text] [Related]
17. Amiodarone versus bretylium for suppression of reperfusion arrhythmias in dogs.
Rosalion A; Snow NJ; Horrigan TP; Noon DL; Mostow ND
Ann Thorac Surg; 1991 Jan; 51(1):81-5. PubMed ID: 1985582
[TBL] [Abstract][Full Text] [Related]
18. A method for quantitating antifibrillatory effects of drugs after coronary reperfusion in dogs: improved outcome with bretylium.
Wenger TL; Lederman S; Starmer CF; Brown T; Strauss HC
Circulation; 1984 Jan; 69(1):142-8. PubMed ID: 6689638
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment with sarafotoxin 6c prior to coronary occlusion protects against infarction and arrhythmias via cardiomyocyte mitochondrial K(ATP) channel activation in the intact rabbit heart during ischemia/reperfusion.
Das B; Sarkar C; Shankar PR
Cardiovasc Drugs Ther; 2007 Aug; 21(4):243-51. PubMed ID: 17520332
[TBL] [Abstract][Full Text] [Related]
20. Effects of anipamil on electrocardiogram, plasma creatine kinase, and reperfusion arrhythmias after coronary occlusion in closed-chest rats.
Kirchengast M; Raschack M
J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S73-5. PubMed ID: 2475696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
